Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase

Little is known about the impact of pretreatment drug resistance (PDR) on the efficacy of second generation integrase inhibitors. We sequenced pretreatment plasma specimens from the ADVANCE trial (NCT03122262). Our primary outcome was 96-week virologic success, defined as a sustained viral load <...

Descripción completa

Detalles Bibliográficos
Autores principales: Siedner, Mark J., Moorhouse, Michelle A., Simmons, Bryony, de Oliveira, Tulio, Lessells, Richard, Giandhari, Jennifer, Kemp, Stephen A., Chimukangara, Benjamin, Akpomiemie, Godspower, Serenata, Celicia M., Venter, Willem D. F., Hill, Andrew, Gupta, Ravindra K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708638/
https://www.ncbi.nlm.nih.gov/pubmed/33262331
http://dx.doi.org/10.1038/s41467-020-19801-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708638/
https://www.ncbi.nlm.nih.gov/pubmed/33262331
http://dx.doi.org/10.1038/s41467-020-19801-x

Ejemplares similares